Chemfab Alkalis Falls to 52-Week Low of Rs.481.1 Amidst Continued Downtrend

The stock recorded an intraday low of Rs.481.1, representing a 7.7% drop within the trading session. Over the last two days, Chemfab Alkalis has experienced a cumulative return decline of 4.1%, underperforming its sector by 1.54% today. This movement has pushed the stock below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish pressure.

Market volatility has been notable, with the stock exhibiting an intraday volatility of 5.66%, calculated from the weighted average price. This heightened price fluctuation contrasts with the broader market, where the Sensex opened 91.42 points higher but later retreated by 177.22 points, currently trading at 84,865.15, just 0.5% shy of its 52-week high of 85,290.06. The Sensex remains above its 50-day moving average, which itself is positioned above the 200-day moving average, indicating a generally bullish market trend despite Chemfab Alkalis’ underperformance.

Examining the stock’s year-long trajectory, Chemfab Alkalis has recorded a negative return of 48.28%, a stark contrast to the Sensex’s positive 9.71% return over the same period. The stock’s 52-week high was Rs.1,186.05, highlighting the extent of the decline. This performance is further underscored by the company’s financial results, which have shown a consistent downward trend over the past quarters.

Financial disclosures reveal that Chemfab Alkalis has reported negative results for ten consecutive quarters. The latest quarter’s Profit Before Tax (PBT) excluding other income stood at Rs. -3.09 crore, reflecting a fall of 316.1% compared to the previous four-quarter average. Similarly, the Profit After Tax (PAT) was Rs. -2.01 crore, down by 274.8% relative to the same benchmark. Net sales for the quarter were Rs. 76.56 crore, showing a decline of 12.3% against the previous four-quarter average.

Over the last five years, the company’s operating profit has exhibited a negative compound annual growth rate of 6.47%, indicating challenges in sustaining long-term growth. The recent quarter ending September 2025 reported a 16.36% fall in net sales, contributing to what has been characterised as very negative results for the period.

Despite these financial headwinds, Chemfab Alkalis maintains a low average debt-to-equity ratio of 0.07 times, suggesting limited leverage on its balance sheet. However, the company’s Return on Capital Employed (ROCE) stands at 2%, which, combined with an enterprise value to capital employed ratio of 1.8, points to a valuation that is relatively expensive compared to its peers’ historical averages.

In terms of market participation, domestic mutual funds hold a modest stake of 0.25% in Chemfab Alkalis. Given their capacity for detailed research and on-the-ground analysis, this relatively small holding may reflect a cautious stance towards the stock’s current valuation and business outlook.

Comparatively, the broader BSE500 index has generated returns of 8.57% over the past year, further emphasising Chemfab Alkalis’ underperformance within the market. The stock’s recent price action and financial disclosures highlight ongoing concerns that have contributed to its decline to the 52-week low.

Overall, Chemfab Alkalis’ current market position is characterised by a significant price correction, subdued financial metrics, and valuation considerations that distinguish it from its sector peers. The stock’s fall to Rs.481.1 marks a notable point in its recent trading history, reflecting a combination of company-specific and market factors.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →